ConductScience.org, home

Paper37568616

Clinical Significance of Early Venous Filling Detected via Preoperative Angiography in Glioblastoma.

Tatebayashi K and 10 others. Cancers (Basel), 2023. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Clinical Significance of Early Venous Filling Detected via Preoperative Angiography in Glioblastoma. Papers, record 37568616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37568616

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical Significance of Early Venous Filling Detected via Preoperative Angiography in Glioblastoma.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2026-03-10
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tatebayashi KKotaro
2Nakayama NNoriyuki
3Sakamoto DDaisukehttps://orcid.org/0000-0003-0076-146X
4Iida TTomoko
5Ono SShun
6Matsuda IIkuo
7Enomoto YYukiko
8Tanaka MMichihiro
9Fujita MMitsuguhttps://orcid.org/0000-0002-0000-9879
10Hirota SSeiichi
11Yoshimura SShinichihttps://orcid.org/0000-0001-9932-2162

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
noneHyogo Medical University Grant for Research Promotion, 2022.PubMed

Source PubMed

Download CSV of grants

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132359215Association between glioblastoma cell-derived vessels and poor prognosis of the patients.Cancer Commun (Lond)2020https://conductscience.org/library/papers/32359215PubMed
226899730Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis.Angiogenesis2016https://conductscience.org/library/papers/26899730PubMed
334967558Diagnostic Accuracy of Immunohistochemistry in Detecting MGMT Methylation Status in Patients with Glioma.Asian Pac J Cancer Prev2021https://conductscience.org/library/papers/34967558PubMed
415758010MGMT gene silencing and benefit from temozolomide in glioblastoma.N Engl J Med2005https://conductscience.org/library/papers/15758010PubMed
526453565Anatomical specificity of vascular endothelial growth factor expression in glioblastomas: a voxel-based mapping analysis.Neuroradiology2016https://conductscience.org/library/papers/26453565PubMed
614976322Appearance of early venous filling during intra-arterial reperfusion therapy for acute middle cerebral artery occlusion: a predictive sign for hemorrhagic complications.Stroke2004https://conductscience.org/library/papers/14976322PubMed
710487832Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.Am J Pathol1999https://conductscience.org/library/papers/10487832PubMed
833472628The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment.Cancer Cell Int2021https://conductscience.org/library/papers/33472628PubMed
911220379Intratumoral arteriovenous shunting in malignant gliomas.Neurosurgery2001https://conductscience.org/library/papers/11220379PubMed
1033465401Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target.Pharmacol Ther2021https://conductscience.org/library/papers/33465401PubMed
1120631803The shunt problem: control of functional shunting in normal and tumour vasculature.Nat Rev Cancer2010https://conductscience.org/library/papers/20631803PubMed
1220888136Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma.Int J Radiat Oncol Biol Phys2011https://conductscience.org/library/papers/20888136PubMed
1331713017Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation.J Neurooncol2020https://conductscience.org/library/papers/31713017PubMed
145642293Early venous filling in cranial angiography.Radiology1968https://conductscience.org/library/papers/5642293PubMed
1511559541Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.Cancer Res2001https://conductscience.org/library/papers/11559541PubMed
1626847813Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.J Neurooncol2016https://conductscience.org/library/papers/26847813PubMed
1734803608Non-Coding RNAs in Glioma Microenvironment and Angiogenesis.Front Mol Neurosci2021https://conductscience.org/library/papers/34803608PubMed
1824552317A randomized trial of bevacizumab for newly diagnosed glioblastoma.N Engl J Med2014https://conductscience.org/library/papers/24552317PubMed
1934359588Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade.Cancers (Basel)2021https://conductscience.org/library/papers/34359588PubMed
2027756883Bevacizumab and wound-healing complications: a systematic review and meta-analysis of randomized controlled trials.Oncotarget2016https://conductscience.org/library/papers/27756883PubMed

See all 27 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
38275409CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review.Biomedicines2024https://conductscience.org/library/papers/38275409

Source PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
IDH13417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene
MGMT4255PubTator's text mininghttps://conductscience.org/library/genes/4255NCBI Gene
MIB157534PubTator's text mininghttps://conductscience.org/library/genes/57534NCBI Gene
PECAM15175PubTator's text mininghttps://conductscience.org/library/genes/5175NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37568616

GET https://conductscience.org/api/papers/v1/37568616/references?page=2